To check the effect and safety of capsule Ocemic in Otitis Media

A Clinical trial: Efficacy and safety of cap Ocemic in Otitis Media

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/06/043609

Enrollment

Registered

2022-06-30

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H720- Central perforation of tympanic membrane

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients of having otitis media both asom and csom 2 age group between 15 to 60 years irrespective of gender and religion and socio economical class

Exclusion criteria

Exclusion criteria: 1Patients with age below 15 years and above 60 years 2 recently ear operated patients 3 patients who are suffering from bleeding from ear 4 patients having CSF otorrhoea and cholesteatoma

Design outcomes

Primary

Measure	Time frame
tab.ocemic is effective and safe to reduce or stop ear discharge in asom and csomTimepoint: 11 days study with 4 follow up (3rd,6th,9th,11th)	—

Secondary

Measure	Time frame
To decrease in symptoms like fullness in the ear otalgia and deafnessTimepoint: 11 days study with 4 follow up (3rd,6th,9th,11th)	—

Countries

India

Contacts

Public ContactDrGajanan Patil

Bharati Vidyapeeth deemed to be University College of Ayurved and Hospital Pune

drgajananpatil1984@gmail.com9923037117

Outcome results